基于环硫酰胺的衍生物作为诺如病毒抑制剂。
Cyclosulfamide-based derivatives as inhibitors of noroviruses.
机构信息
Department of Chemistry, Wichita State University, Wichita, KS 67260, USA.
出版信息
Eur J Med Chem. 2012 Jan;47(1):59-64. doi: 10.1016/j.ejmech.2011.10.019. Epub 2011 Oct 20.
Abstract
An optimization campaign focused on improving pharmacological activity and physicochemical properties of a recently-identified class of cyclosulfamide-based norovirus inhibitors has been carried out. Dimeric compound 4 was found to be a ∼10-fold more potent norovirus inhibitor (ED(50) 0.4 μM) compared to the original hit, however, isonipecotic acid ester derivatives 7e and 10a were shown to have superior therapeutic indices.
摘要
一项旨在改善最近发现的一类基于环硫酰胺的诺如病毒抑制剂的药理活性和物理化学性质的优化活动已经开展。二聚体化合物 4 被发现比原始命中物具有约 10 倍更高的诺如病毒抑制活性（ED(50)0.4μM），然而，异哌啶酸酯衍生物 7e 和 10a 显示出更好的治疗指数。
相似文献
1
Cyclosulfamide-based derivatives as inhibitors of noroviruses.基于环硫酰胺的衍生物作为诺如病毒抑制剂。
Eur J Med Chem. 2012 Jan;47(1):59-64. doi: 10.1016/j.ejmech.2011.10.019. Epub 2011 Oct 20.
2
Design and synthesis of inhibitors of noroviruses by scaffold hopping.通过骨架跃迁设计和合成诺如病毒抑制剂。
Bioorg Med Chem. 2011 Oct 1;19(19):5749-55. doi: 10.1016/j.bmc.2011.08.032. Epub 2011 Aug 22.
3
Discovery and Synthesis of Heterocyclic Carboxamide Derivatives as Potent Anti-norovirus Agents.作为强效抗诺如病毒剂的杂环甲酰胺衍生物的发现与合成
Chem Pharm Bull (Tokyo). 2016;64(5):465-75. doi: 10.1248/cpb.c16-00001.
4
Inhibition of noroviruses by piperazine derivatives.哌嗪衍生物对诺如病毒的抑制作用。
Bioorg Med Chem Lett. 2012 Jan 1;22(1):377-9. doi: 10.1016/j.bmcl.2011.10.122. Epub 2011 Nov 15.
5
Potent norovirus inhibitors based on the acyclic sulfamide scaffold.基于无环磺酰胺骨架的强效诺如病毒抑制剂。
Bioorg Med Chem. 2012 Mar 15;20(6):2111-8. doi: 10.1016/j.bmc.2012.01.030. Epub 2012 Feb 2.
6
Structure-Guided Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease.基于结构的诺如病毒 3CL 蛋白酶二肽抑制剂优化。
J Med Chem. 2020 Oct 22;63(20):11945-11963. doi: 10.1021/acs.jmedchem.0c01252. Epub 2020 Oct 2.
7
Potent inhibition of Norwalk virus by cyclic sulfamide derivatives.环磺酰胺衍生物对诺如病毒的强效抑制作用。
Bioorg Med Chem. 2011 Oct 15;19(20):5975-83. doi: 10.1016/j.bmc.2011.08.054. Epub 2011 Aug 27.
8
Identification of novel non-nucleoside vinyl-stilbene analogs as potent norovirus replication inhibitors with a potential host-targeting mechanism.鉴定新型非核苷乙烯基二苯乙烯类似物作为有效的诺如病毒复制抑制剂，具有潜在的宿主靶向机制。
Eur J Med Chem. 2019 Dec 15;184:111733. doi: 10.1016/j.ejmech.2019.111733. Epub 2019 Sep 26.
9
Molecular design, synthesis, and biological evaluation of bisamide derivatives as cyclophilin A inhibitors for HCV treatment.作为 HCV 治疗的环孢素 A 抑制剂的双酰胺衍生物的分子设计、合成和生物评价。
Eur J Med Chem. 2020 Feb 15;188:112031. doi: 10.1016/j.ejmech.2019.112031. Epub 2020 Jan 2.
10
Discovery, design and synthesis of the first reported potent and selective sphingosine-1-phosphate 4 (S1P4) receptor antagonists.首次报道的强效和选择性鞘氨醇-1-磷酸 4（S1P4）受体拮抗剂的发现、设计和合成。
Bioorg Med Chem Lett. 2011 Jun 15;21(12):3632-6. doi: 10.1016/j.bmcl.2011.04.097. Epub 2011 Apr 28.
引用本文的文献
1
Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.针对诺如病毒和轮状病毒的治疗与免疫预防：过去、现在与未来
Curr Drug Metab. 2018;19(3):170-191. doi: 10.2174/1389200218666170912161449.
2
Structure-based design and synthesis of triazole-based macrocyclic inhibitors of norovirus protease: Structural, biochemical, spectroscopic, and antiviral studies.基于结构的诺如病毒蛋白酶三唑基大环抑制剂的设计与合成：结构、生化、光谱及抗病毒研究
Eur J Med Chem. 2016 Aug 25;119:300-18. doi: 10.1016/j.ejmech.2016.04.013. Epub 2016 Apr 25.
3
Asymmetric Palladium-Catalyzed Alkene Carboamination Reactions for the Synthesis of Cyclic Sulfamides.用于合成环状磺酰胺的不对称钯催化烯烃碳胺化反应
Chemistry. 2016 Apr 18;22(17):5919-22. doi: 10.1002/chem.201600887. Epub 2016 Mar 10.
4
Anti-norovirus therapeutics: a patent review (2010-2015).抗诺如病毒疗法：专利综述（2010 - 2015年）
Expert Opin Ther Pat. 2016;26(3):297-308. doi: 10.1517/13543776.2016.1153065.
5
Recent Advances in the Discovery of Norovirus Therapeutics.诺如病毒治疗方法发现的最新进展
J Med Chem. 2015 Dec 24;58(24):9438-50. doi: 10.1021/acs.jmedchem.5b00762. Epub 2015 Aug 17.
6
Structure-guided design and optimization of dipeptidyl inhibitors of norovirus 3CL protease. Structure-activity relationships and biochemical, X-ray crystallographic, cell-based, and in vivo studies.诺如病毒3CL蛋白酶二肽基抑制剂的结构导向设计与优化。构效关系以及生化、X射线晶体学、细胞水平和体内研究。
J Med Chem. 2015 Apr 9;58(7):3144-55. doi: 10.1021/jm5019934. Epub 2015 Mar 19.
7
Vicinal diamination of alkenes under Rh-catalysis.铑催化下烯烃的邻位双胺化反应。
J Am Chem Soc. 2014 Oct 1;136(39):13506-9. doi: 10.1021/ja506532h. Epub 2014 Sep 18.
8
Influence of catalyst structure and reaction conditions on anti- versus syn-aminopalladation pathways in Pd-catalyzed alkene carboamination reactions of N-allylsulfamides.催化剂结构和反应条件对钯催化的N-烯丙基磺酰胺烯烃碳胺化反应中反式与顺式氨基钯化途径的影响。
Chemistry. 2014 Jul 7;20(28):8782-90. doi: 10.1002/chem.201402258. Epub 2014 Jun 17.
9
Treatment of norovirus infections: moving antivirals from the bench to the bedside.诺如病毒感染的治疗：将抗病毒药物从实验室推向临床。
Antiviral Res. 2014 May;105:80-91. doi: 10.1016/j.antiviral.2014.02.012. Epub 2014 Feb 25.
10
Structural and inhibitor studies of norovirus 3C-like proteases.诺如病毒 3C 样蛋白酶的结构和抑制剂研究。
Virus Res. 2013 Dec 26;178(2):437-44. doi: 10.1016/j.virusres.2013.09.008. Epub 2013 Sep 17.
本文引用的文献
1
Potent inhibition of Norwalk virus by cyclic sulfamide derivatives.环磺酰胺衍生物对诺如病毒的强效抑制作用。
Bioorg Med Chem. 2011 Oct 15;19(20):5975-83. doi: 10.1016/j.bmc.2011.08.054. Epub 2011 Aug 27.
2
Design and synthesis of inhibitors of noroviruses by scaffold hopping.通过骨架跃迁设计和合成诺如病毒抑制剂。
Bioorg Med Chem. 2011 Oct 1;19(19):5749-55. doi: 10.1016/j.bmc.2011.08.032. Epub 2011 Aug 22.
3
Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments.基于 NMR 实验的靶向诺如病毒感染——多价进入抑制剂设计。
Chemistry. 2011 Jun 27;17(27):7442-53. doi: 10.1002/chem.201003432. Epub 2011 May 12.
4
"Double-click" protocol for synthesis of heterobifunctional multivalent ligands: toward a focused library of specific norovirus inhibitors.用于合成异双功能多价配体的“双击”协议：迈向特定诺如病毒抑制剂的聚焦文库
Chemistry. 2011 Jun 27;17(27):7438-41. doi: 10.1002/chem.201003414. Epub 2011 Apr 5.
5
Biodegradable nanogels for oral delivery of interferon for norovirus infection.用于诺如病毒感染的干扰素口服递送的可生物降解纳米凝胶。
Antiviral Res. 2011 Feb;89(2):165-73. doi: 10.1016/j.antiviral.2010.11.016. Epub 2010 Dec 7.
6
Noroviruses - State of the Art.诺如病毒——最新进展
Food Environ Virol. 2010;2(3):117-126. doi: 10.1007/s12560-010-9038-1.
7
Noroviruses: The leading cause of gastroenteritis worldwide.诺如病毒：全球范围内肠胃炎的主要病因。
Discov Med. 2010 Jul;10(50):61-70.
8
Antiviral strategies to control calicivirus infections.控制杯状病毒感染的抗病毒策略。
Antiviral Res. 2010 Aug;87(2):162-78. doi: 10.1016/j.antiviral.2010.05.002. Epub 2010 May 21.
9
Privileged scaffolds for library design and drug discovery.优先支架用于文库设计和药物发现。
Curr Opin Chem Biol. 2010 Jun;14(3):347-61. doi: 10.1016/j.cbpa.2010.02.018. Epub 2010 Mar 18.
10
Role of cholesterol pathways in norovirus replication.胆固醇途径在诺如病毒复制中的作用。
J Virol. 2009 Sep;83(17):8587-95. doi: 10.1128/JVI.00005-09. Epub 2009 Jun 10.
Zotero 插件